KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2025)

Amneal Pharmaceuticals (AMRX) has 5 years of Asset Utilization Ratio data on record, last reported at 0.8 in Q4 2024.

  • For Q4 2024, Asset Utilization Ratio changed N/A year-over-year to 0.8; the TTM value through Dec 2024 reached 0.8, changed N/A, while the annual FY2024 figure was 0.8, 21.71% up from the prior year.
  • Asset Utilization Ratio reached 0.8 in Q4 2024 per AMRX's latest filing, up from 0.77 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.8 in Q4 2024 and bottomed at 0.42 in Q1 2020.
  • Average Asset Utilization Ratio over 4 years is 0.6, with a median of 0.55 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: dropped 0.73% in 2020, then rose 19.71% in 2021.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.42 in 2020, then rose by 26.96% to 0.53 in 2021, then rose by 8.98% to 0.58 in 2022, then surged by 39.19% to 0.8 in 2024.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.8 in Q4 2024, 0.77 in Q3 2024, and 0.58 in Q4 2022.